Shanghai United Imaging Healthcare Co., Ltd.

Otis Elevator Company

Carrier Corporation

Honeywell International Inc.

General Electric Company

Huawei Technologies Co., Limited

Shanghai Huali Microelectronics Corporation

Pixelworks, Inc.

Intel Corporation

Cisco Technology, Inc.

Murata Manufacturing Co., Ltd.

Konica Minolta, Inc.

Konica Minolta Business Technologies, Inc.

Cooper Technologies Company

Basf Coatings Gmbh

Qiang Li

Jianwei Zhao

Hui Fang

Zhen Jia

Alan Matthew Finn

Anna Su

Xin Zhou

LongWen Wang

ZhaoXia Hu

Yuncheng Zheng

Si Ruo Chen

Alois Senger

Minqi Xin

Xinlu Ma

Yuanli Li

Yongjuan Gao

Yanli Song

Minghua Luo

Zhaoxia Hu

Luan Jiang

Shan Ling

Wilfrid Fuchs

Bill Nai-Chau Sun

Lu Yang

Neil Woodall

Arthur Hsu

Jing Wang

Guobin Li

Fei Shen

Gang Chen

Pablo Bandera

Ryuji Kitani

Tao Sun

Shaohui An

Tongtong Xue

Chaohong Wang

Yanzhi Chen

Liang Xiao

Lei Gao

Gero Gschwendtner

Yanying Chen

Wenqiang Li

Dengnian Liu

JianGuo Li

Liang Cai

Jason Dai

Yonghui Zhang

Nicholas Joseph Kray

Yu Zhang

Hui Li

Jianguo Li

Yi Bu Li

Jingyi Wang

Yong Yang

Ming Xie

Wei Guo

Bob Zhang

Xin Xu

Lichun Wang

Fan Yang

John V Lovelace

Zhen Zhang

Zhihui Zhang

Junhua Chen

Xu Fu

Xiaojun Wang

Hai Qiu

Guodong Liu

Guan Zhong Wang

Minghui Yang

Tod Winton Davis

Gerald Alexander Pauley

Hui Xie

Jia Chen

Yunfei Li

Lee-Hwei King Sun

Jian Ge

Yijin Wang

Prasad Babu Lakshmipathy

Le Gao

Yasuharu Saita

Xiaohua Wang

Masashi Mamino

Wen Wei

Zhenxiang Hu

Ke Pan

Stefan Hirsemann

Suzankumar Gongate

Zhilin Wu

Gangmin Cao

Sowmya Paturu

Jorge Orlando Lamboy

Yun Bai

Sreeramya Soratkal

Nigel Bruce Morris

Lihan He

Liming Zhang

Xueyan Wang

Sanming Wen

Xiaoer Xia

The present disclosure discloses a non-isolated LLC resonant converter, comprising a first switch network module, a second switch network module, a resonance network module, a transformer module, a rectification network module and an output module, wherein via signals under drive control input on the first switch network module, the second switch network module and the rectification network module, it is controlled to realize zero-voltage switching (ZVS) and zero-current switching (ZCS) of a switch in a resonant state, thereby reducing switching loss of a switch unit, improving electric energy conversion efficiency and reducing production cost and power density, wherein simultaneously a quantity of turns of a primary winding of a transformer is saved, a loss of the primary winding of the transformer is reduced, a manufacturing cost of the power converter is reduced, simultaneously, a space of a transformer winding is saved, and design requirements of smaller volume are realized.

Non-isolated LLC resonant converter

Related are a JAK kinase inhibitor, a preparation method for same, and applications thereof in the field of medicine, related to the field of medicinal chemistry. Provided is a novel small molecule JAK inhibitor, which has the structure as represented by formula (II). The compound provides improved efficacy and safeness in preventing or treating a JAK-related indication.

JAK kinase inhibitor, preparation method for same, and applications thereof in field of medicine

A display module and an electronic device are provided. The display module includes a display and a support. The display includes a first non-bending region, a bending region, and a second non-bending region. The support is fastened to a non-display side of the display. The support includes a first metal plate, a third metal plate, a second metal plate, and a first buffer. The first metal plate is disposed facing the first non-bending region. The second metal plate is disposed facing the second non-bending region. The third metal plate is disposed facing the bending region, and the third metal plate can be bent. The first buffer is located between the first metal plate and the second metal plate.

Display module with a bendable region and non-bendable region, and electronic device

This application provides a display module and an electronic device. A display module includes a first buffer member, and a first non-bending region, a bending region, and a second non-bending region. A support member is fastened on the display screen. A first metal plate member of the support member faces the first non-bending region. A first connection plate member of the support member faces the bending region. A second metal plate member of the support member faces the second non-bending region. The first connection plate member is provided with grooves. Openings of the grooves are located on a first surface of the metal part. Organic material are located in the grooves, and are connected to the metal part. The first buffer member is located between the first metal plate member and the second metal plate member.

Bendable display module and device

The present application discloses a method and apparatus for controlling a motorcycle, a system, a motorcycle and a storage medium. The method includes: acquiring a first wheel speed signal and a second wheel speed signal; calculating a difference between the first wheel speed signal and the second wheel speed signal; detecting whether the difference satisfies a first condition, the first condition being used for detecting whether to adjust ignition timing of an engine; if the difference satisfies the first condition, detecting whether the exhaust temperature of the engine exceeds a temperature threshold; if the exhaust temperature does not exceed the temperature threshold, determining an ignition plug ignition angle of the engine according to the difference and the rotating speed of the engine; and adjusting the ignition timing of the engine according to the ignition plug ignition angle.

Method and apparatus for controlling motorcycle, system, motorcycle and storage medium

The invention provided herein relates to methods and uses of a bispecific antibody, which specifically binds the surface antigen CD3 of immune cells and the BCMA antigen on the surface of tumor cells and which may bind to human CD3 with high affinity, induce T cell proliferation, and mediate tumor cell killing effects. The bispecific antibody may be used to mediate the T cell-specific killing of target cells in in vitro tests.

Bispecific antibody binding BCMA and CD3

The present disclosure relates to a program verification method and apparatus, a platform, a user terminal, and an online service system, includes: acquiring a root evidence of a server-side program from a blockchain network, and acquiring a verification evidence of the server-side program from a server side, where the root evidence is written into the blockchain network after server-side program review succeeds, and the success of the server-side program review indicates a data processing method of the server-side program satisfies a preset data processing rule; verifying whether the root evidence and the verification evidence are matched, where the root evidence and the verification evidence being matched indicates the server-side program is a program that is operated in a TEE of a computer and is not modified after the root evidence is written into the blockchain network; and determining to connect a user-side program to the server-side program.

Program verification method and apparatus, platform, user terminal, and online service system

An ultralow-gloss polycarbonate/acrylonitrile-butadiene-styrene (PC/ABS) resin composition and a preparation method thereof are provided. The composition includes the following components: 40-80 parts by weight of bisphenol A polycarbonate, 19-40 parts by weight of acrylonitrile-butadiene-styrene graft copolymer, 1-20 parts by weight of ultralow-gloss toughening modifier, and 0.1-5 parts of processing aid. The ultralow-gloss toughening modifier includes the following components: post-treated polymeric microspheres, a low-temperature toughening agent, a coupling agent, and aid. The preparation method of the composition includes: fully mixing all components in a high-speed mixer to obtain a mixture; feeding the mixture into a main feed port from a twin-screw extruder, melting, extruding, cooling, drying, and pelletizing. The PC/ABS resin composition prepared by the present invention has extremely low gloss level and excellent impact toughness, and it can be applied in scenarios requiring low temperature resistance and low gloss level.

Ultralow-gloss PC/ABS resin composition and preparation method thereof

The present disclosure relates to a dual-function protein for regulating blood glucose and lipid metabolism, wherein said dual-function protein comprises a human GLP-1 analog and human FGF21. In the present disclosure, provided is a method for preparing said dual function protein, and also provided is the use of said dual-function protein in the preparation of a biological substance for treating type 2 diabetes, obesity, dyslipidemia, fatty liver disease and/or metabolic syndrome. The dual-function protein provided in the present disclosure can synergistically regulate blood glucose and lipid levels in vivo, and satisfy multiple requirements for patients with type 2 diabetes such as lowering blood glucose, relieving hepatic steatosis, reducing body weight and improving metabolic disorders of circulating lipids.

Dual-function protein for lipid and blood glucose regulation

The present disclosure provides a method and apparatus for parsing contiguous system addresses, and an electronic device. The method for parsing contiguous system addresses comprises: acquiring system level information upon receiving contiguous system addresses; acquiring logical address ranges of objects in a first level based on the contiguous system addresses and the system level information; and when successively acquiring logical address ranges of objects in a second level, . . . , or an Nth level of the system, acquiring logical address ranges of objects in a present level based on a logical address range of a previous level and the system level information, wherein N is the number of levels, and N is an integer greater than or equal to 2, and a logical address range of an object comprises a start address and an end address of the object.

Method and apparatus for parsing contiguous system addresses, and electronic device

Provided by the present invention are an antibody against human TIM-3 or an antigen-binding fragment thereof, and further provided are a nucleic acid molecule encoding the antibody, an expression vector for expressing the antibody and a host cell, and a method for producing the antibody. Further provided by the present invention are a pharmaceutical composition comprising the antibody or an antigen-binding fragment of the antibody, and an application of the pharmaceutical composition in the preparation of a medicine, the medicine is used for preventing and/or treating various diseases (including tumors, infectious diseases and autoimmune diseases).

Antibody against TIM-3 and application thereof

A linker peptide for constructing a fusion protein. The linker peptide comprises a flexible peptide and a rigid peptide. The flexible peptide consists of one or more flexible units. The rigid peptide consists of one or more rigid units. The flexible unit comprises two or more amino acid residues selected from Gly, Ser, Ala, and Thr. The rigid unit comprises a human chorionic gonadotropin &#x3b2;-subunit carboxy-terminal peptide (CTP) bearing a plurality of glycosylation sites. The linker peptide can more effectively eliminate mutual steric hindrance of two fusion molecules, decreasing a reduction/loss of polymerization or activity resulting from improper folding of an active protein or a conformational change. On the other hand, the negatively charged, highly sialylated CTP can resist renal clearance, further prolonging a half-life of a fused molecule and enhancing bioavailability of a fused protein. Furthermore, a protective effect of a glycosylated side chain CTP can lower the protease sensitivity of the linker peptide, making a linker region of the fusion protein less degradable.

Linker peptide for constructing fusion protein

The present invention relates to the field of treatment of diseases and immunology. Specifically, the present invention relates to an anti-LAG-3 antibody or an antigen-binding fragment thereof, nucleic acid molecules for encoding said antibody and fragment, and method for preparing said antibody and fragment. The anti-LAG-3 antibody or the antigen-binding fragment thereof according to the present invention has high specificity and high affinity to LAG-3, can effectively block the binding of LAG-3 to MHC II and/or FGL1, and can inhibit and/or block intracellular signaling mediated by LAG-3 binding to MHC II and/or FGL1. Therefore, the present invention further relates to a pharmaceutical composition comprising the antibody or the antigen-binding fragment thereof, and use of the pharmaceutical composition in the preparation of drugs. The drugs are used for improving the activity of immune cells and enhancing the immune response, or are used for preventing and/or treating tumors, infections or autoimmune diseases.

Anti-LAG-3 antibody and use thereof

The invention provides an antibody and/or an antigen binding fragment that binds to NGF, and the amino acid sequences of the heavy chain and light chain variable regions of the antibody. The NGF antibody and/or its antigen binding fragment provided by the invention has high affinity for NGF and can effectively block the binding between NGF receptor and NGF. This antibody and/or its antigen binding fragment can inhibit the binding activity of NGF and its receptor in vitro, and is suitable for the treatment of pain diseases which are related to the haughty expression or increased expression of NGF.

Anti-human NGF antibodies and methods using same

Air quality detecting device

Growing community of inventors

Shanghai, China

Qiang Li